GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (NSE:TAKE) » Definitions » EV-to-FCF

Take Solutions (NSE:TAKE) EV-to-FCF : (As of May. 22, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Take Solutions EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Take Solutions's Enterprise Value is ₹3,555.5 Mil. Take Solutions's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.0 Mil. Therefore, Take Solutions's EV-to-FCF for today is .

The historical rank and industry rank for Take Solutions's EV-to-FCF or its related term are showing as below:

NSE:TAKE' s EV-to-FCF Range Over the Past 10 Years
Min: -24.41   Med: 0   Max: 40.2
Current: 29.39

During the past 13 years, the highest EV-to-FCF of Take Solutions was 40.20. The lowest was -24.41. And the median was 0.00.

NSE:TAKE's EV-to-FCF is ranked worse than
69.68% of 376 companies
in the Biotechnology industry
Industry Median: 9.49 vs NSE:TAKE: 29.39

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Take Solutions's stock price is ₹21.80. Take Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-4.440. Therefore, Take Solutions's PE Ratio for today is At Loss.


Take Solutions EV-to-FCF Historical Data

The historical data trend for Take Solutions's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Take Solutions EV-to-FCF Chart

Take Solutions Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.34 35.56 7.94 5.23 19.06

Take Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 19.06 - - -

Competitive Comparison of Take Solutions's EV-to-FCF

For the Biotechnology subindustry, Take Solutions's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Take Solutions's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Take Solutions's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Take Solutions's EV-to-FCF falls into.



Take Solutions EV-to-FCF Calculation

Take Solutions's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3555.520/0
=

Take Solutions's current Enterprise Value is ₹3,555.5 Mil.
Take Solutions's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Take Solutions  (NSE:TAKE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Take Solutions's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.80/-4.440
=At Loss

Take Solutions's share price for today is ₹21.80.
Take Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4.440.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Take Solutions EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Take Solutions's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Take Solutions (NSE:TAKE) Business Description

Traded in Other Exchanges
Address
No. 27, Tank Bund Road, Nungambakkam, Chennai, TN, IND, 600 034
Take Solutions Ltd is a technology-driven Clinical Research Organization in India. The company's operating segment includes Life Sciences and generates revenue from the Life Sciences segment. The company serves large and small biopharmaceutical companies as well as generics manufacturers.

Take Solutions (NSE:TAKE) Headlines

No Headlines